Transaction · 0000914190-26-000113

Herr Amy E.

Herr Amy E., DIR, reported a transaction classified as exercise at BIO-TECHNE Corp involving 589.000000 shares for an estimated $0.00. Reported holdings after the transaction were 789.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MDIR
TECHBIO-TECHNE Corp
Trade date
Aug 15, 2026
Filing date
Aug 18, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded589$0.00 per share
Holdings after789Indirect · By significant other
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TECH price since this filing

Daily closing prices, with the filing date and available return windows
TECH · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -0.6%1w ago +0.1%1d ago +0.2%
Returns since7d +0.2%30d +0.3%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0000914190-26-000113
Common Stock
Transaction date
Aug 15, 2026
Filed Aug 18, 2026, 08:12 PM · 3d delay
Shares
589 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
789 sh
Indirect · By significant other

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Large Holdings Increase
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
    Read the scoring methodology

    Signed filing-only points, not a probability or expected return. Version v1.

    Reported relationships & other filings

    Form 4 relationship flags and nearby filing context

    Reported roles

    No officer title

    Officer NoDirector Yes10% NoOther No
    Footnotes & amended
    1. F1

      This option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.

    2. F2

      Fully vested.

    3. F3

      Options to purchase 528 shares vest on 8/15/2023 and 8/15/2025; and options to purchase 524 shares vest on 8/15/2024 and 8/15/2026.

    4. F4

      Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.

    5. F5

      Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.

    6. F6

      Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029.

    7. F7

      Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

    8. F8

      118 restricted stock units vest on 8/15/2026.

    9. F9

      160 restricted stock units vest on each of 8/15/2026 and 8/15/2027.

    10. F10

      38 restricted stock units vest on 2/3/2027 and 39 restricted stock units vest on 2/3/2028.

    11. F11

      311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028.

    12. F12

      Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028.

    Original filing · 0000914190-26-000113
    Related transactions

    0 other transactions

    Same SEC filing
    Recent company activity

    0 recent txs

    TECH